This inventor holds 1 USPTO granted patent. Top assignee: Aktis Oncology, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Stanley Richard Krystek
Introduction: Stanley Richard Krystek is an accomplished inventor based in the United States. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins. His work focuses on addressing various medical conditions through innovative solutions.
Latest Patents: One of his notable inventions is the patent for "Fibronectin Based Scaffold Domain Proteins That Bind To Myostatin." This invention relates to fibronectin-based scaffold domain proteins that bind to myostatin. The therapeutic applications of these proteins aim to treat conditions such as muscular dystrophy, cachexia, sarcopenia, osteoarthritis, osteoporosis, diabetes, obesity, COPD, chronic kidney disease, heart failure, myocardial infarction, and fibrosis.
Career Highlights: Throughout his career, Krystek has demonstrated a commitment to advancing medical science through his research and inventions. His innovative approach has the potential to impact the treatment of various debilitating diseases.
Collaborations: He has collaborated with notable colleagues, including Sharon T Cload and Linda Engle, to further enhance the development of his inventions. These partnerships have contributed to the success of his research endeavors.
Conclusion: Stanley Richard Krystek's work in developing fibronectin-based scaffold domain proteins showcases his dedication to improving healthcare through innovation. His contributions have the potential to make a significant difference in the lives of patients suffering from various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile